Effect of cilostazol, a phosphodiesterase-3 inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes: ESCAPE study.

Dong-Hwa LeeEun Ju ChunTae Jung OhKyoung Min KimJae Hoon MoonSung Hee ChoiKyong Soo ParkHak Chul JangSoo Lim

Published in: Diabetes, obesity & metabolism (2019)

CTZ treatment for 12 months decreased coronary artery stenosis and the non-calcified plaque component. These results suggest that CTZ treatment may be an option for preventing the progression of coronary atherosclerosis in people with diabetes.

Keyphrases

coronary artery
coronary artery disease
pulmonary artery
cardiovascular disease
type diabetes
heart failure
skeletal muscle
pulmonary hypertension
glycemic control
transcatheter aortic valve replacement
ejection fraction